INTRACAMERAL SUSTAINED RELEASE DRUG DELIVERY SYSTEMS
申请人:ALLERGAN, INC.
公开号:EP2411013B1
公开(公告)日:2020-08-19
US7960381B2
申请人:——
公开号:US7960381B2
公开(公告)日:2011-06-14
US8377984B2
申请人:——
公开号:US8377984B2
公开(公告)日:2013-02-19
[EN] SUBSTITUTED GAMMA LACTAMS AS THERAPEUTIC AGENTS<br/>[FR] UTILISATION DE GAMMA LACTAMES SUBSTITUÉS COMME AGENTS THÉRAPEUTIQUES
申请人:ALLERGAN INC
公开号:WO2008094912A2
公开(公告)日:2008-08-07
(EN) A compound comprising or a pharmaceutically acceptable salt, prodrug, or a metabolite thereof is disclosed herein. Y, A, and B are as described herein. Methods, compositions, and medicaments related to these compounds are also disclosed.(FR) Cette invention se rapporte à un composé comprenant des gamma lactames substitués ou un de ses sels pharmaceutiquement acceptables, un promédicament ou un métabolite. Y, A et B sont tels qu'énoncés dans la description. L'invention concerne également des procédés, des compositions et des médicaments associés à ces composés.
[EN] SUBSTITUTED GAMMA LACTAMS AS THERAPEUTIC AGENTS<br/>[FR] GAMMA LACTAMES SUBSTITUÉS EN TANT QU'AGENTS THÉRAPEUTIQUES
申请人:ALLERGAN INC
公开号:WO2009097223A1
公开(公告)日:2009-08-06
Disclosed herein is a compound represented by the formula: (I) Methods, compositions, and medicaments related to these compounds are also disclosed. These compounds are useful for treating glaucoma and ocular hypertension as well as for growing hair or improving the appearance of hair.